OPDP

dominoes stop stall halt end red
Marketing

FDA ad watchers take umbrage at Xeris' 'misleading claims'

After a long hiatus, the FDA's watchdog, the Office of Prescription Drug Promotion, has taken issue with a pharmaceutical company's drug promotion.
Ben Adams Jun 14, 2023 9:15am
FDA

FDA to study how patients, physicians choose prescription drugs

Apr 26, 2022 10:55am
Getty Images photo with girl listening attentively holding her palm to her ear

Good ad or bad ad? FDA reminds docs about its Bad Ad program

Sep 20, 2021 11:46am
Biohaven Nurtec ODT spokesperson Khloe Kardashian

Biohaven smacked for a Kardashian's TV show guest chat

Mar 10, 2021 8:06am
FDA Building

FDA dings Azurity for misleading leukemia drug email to doctors

Dec 7, 2020 11:03am
FDA Building 2

FDA ad watchdog slaps 2 pharmas with warning letters

Oct 7, 2020 10:25am